Drug Shortage Report for INSPRA

Last updated on 2017-08-11 History
Report ID 16559
Drug Identification Number 02323052
Brand name INSPRA
Common or Proper name Inspra
Company Name PFIZER CANADA ULC
Active Ingredient(s) EPLERENONE
Strength(s) 25MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 3 x 10 TABS
ATC code C03DA
ATC description POTASSIUM-SPARING AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-07-20
Actual start date
Estimated end date 2017-08-10
Actual end date 2017-08-10
Shortage status Resolved
Updated date 2017-08-11
Company comments Resolved August 10, 2017. Product currently under allocation
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2017-08-11 English Compare
v9 2017-08-10 French Compare
v8 2017-08-10 English Compare
v7 2017-08-07 French Compare
v6 2017-08-07 English Compare
v5 2017-08-02 French Compare
v4 2017-08-02 English Compare
v3 2017-07-21 English Compare
v2 2017-07-20 French Compare
v1 2017-07-20 English Compare